Valuation UCB

Stocks

Market Closed - Euronext Bruxelles Other stock markets 01:55:00 25/07/26 am AEST			5-day change	1st Jan Change
246.00 ^EUR	+1.23%		+2.80%	+3.10%

15/07	Where would AI lead Pharma in the long run?
13/07	Antengene Receives $60 Million Milestone in UCB Licensing Deal	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	46,829	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	3.3%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	46,587	44,506	41,971
Change	-	-19.36%	7.34%	121.15%	19.54%	2.78%	-4.47%	-5.69%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	26.4x	20.9x	16.8x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.98x	3.42x	2.82x
PEG	-	-0.6x	-2.2x	0x	0.6x	1.9x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	5.48x	4.86x	4.35x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	5.45x	4.62x	3.9x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	16x	12.4x	9.81x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	19.9x	15.1x	11.4x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	23.6x	17.1x	13.4x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.24%	5.85%	7.45%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.465	1.505	1.538
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.6%	0.61%	0.63%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.334	11.76	14.66
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	15.7%	12.8%	10.5%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,543	9,644	10,756
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	2,907	3,599	4,278
EBIT ¹	1,318	675	657	836	2,009	2,345	2,957	3,666
Net income ¹	1,058	418	343	1,065	1,558	1,770	2,277	2,835
Net Debt ¹	860	2,000	2,177	1,454	-7	-242.2	-2,323	-4,858
Reference price ²	100.35	73.56	78.90	192.20	238.60	246.00	246.00	246.00
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,361	-	-
Announcement Date	24/2/22	22/2/23	28/2/24	27/2/25	24/2/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
UCB	26.36x	5.45x	16.03x	0.6%	53.32B
REGENERON PHARMACEUTICALS, INC.	17.35x	3.71x	9.57x	0.59%	66.74B
SAMSUNG BIOLOGICS CO.,LTD.	37.26x	12.6x	24.05x	-.--%	48.12B
CSL LIMITED	-42.39x	3.06x	9.03x	3.57%	38.25B
BIOGEN INC.	25.06x	3.49x	11.87x	-.--%	29.85B
INCYTE CORPORATION	56.96x	3.39x	25.31x	-.--%	23.51B
MODERNA, INC.	-6.24x	8.61x	-5.3x	-.--%	21.45B
BRIDGEBIO PHARMA, INC.	-37.77x	18x	-49.29x	-.--%	16.47B
SWEDISH ORPHAN BIOVITRUM AB	24.05x	5.15x	13.48x	-.--%	16.38B
AXSOME THERAPEUTICS, INC.	-116.91x	12.56x	-89.89x	-.--%	12.4B
Average	-1.63x	7.60x	-3.51x	0.48%	32.65B
Weighted average by Cap.	9.22x	6.64x	6.51x	0.64%